Antipsychotic Use in Pregnancy and the Risk for Congenital Malformations

Abstract

Evidence from this large study suggests that use of APs early in pregnancy generally does not meaningfully increase the risk for congenital malformations overall or cardiac malformations in particular. The small increase in the risk for malformations observed with risperidone requires additional study.